Satoris raises $5M, preps Alzheimer's test for research use

Redwood City, Calif.-based Satoris, a biotech developing a blood test for Alzheimer’s disease, raised $5 million in a second funding round, VentureWire reports. The deal values Satoris at $13.8 million after the financings. The company had previously raised $1 million from individuals, and said it will seek another $15 million this year.

Life sciences briefing: Wednesday, Oct. 17, 2007

Featured companies: Algorithme Pharma, Bacchus Vascular, Botaneco, Cubist Pharmaceuticals, Ikonisys, Healthcare Management Systems, Illumigen Biosciences, Kilmer Capital Partners, Medical Specialties Distributors, Metastatix, Microphage, Orthosoft, Thomas McNerney & Partners, TranS1, TriReme Medical, Wren Medical, Zimmer